David D O'Toole
CIK 1491140 · CFO · last filed 2026-06-12
David D O'Toole is a CFO who has filed 75 SEC Form 4 insider transactions across 7 companies since 2010. The most recent filing shows the insider was granted $7.9K of RCEL on Jun 12, 2026. Across all open-market trades the lifetime net is +$611.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $877.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$877.7K
7
75
$611.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RCEL | CFO | 152,927 | $4.61 | $705.0K | $348.0K | 26 | 2026-06-12 |
| OPIANT PHARMACEUTICALS, INC. (OPNT) Delisted | Chief Financial Officer | 0 | $20.65 | $0 | $113.7K | 24 | 2023-03-03 |
| SOLENO THERAPEUTICS INC (CAPNW) Delisted | Director | — | — | — | $0 | 1 | 2017-04-24 |
| SOLENO THERAPEUTICS INC (CAPN.W) Delisted | See Remarks | 44,750 | — | — | $94.4K | 12 | 2016-08-19 |
| CDXS | SVP & Chief Financial Officer | 110,687 | $1.50 | $166.0K | $45.1K | 6 | 2013-09-06 |
| MNOV | Director | 5,000 | $1.33 | $6.7K | $8.9K | 2 | 2012-05-30 |
| RESPONSE GENETICS INC (RGDX) Delisted | VP and Chief Financial Officer | 1,000 | — | — | $1.5K | 4 | 2012-02-06 |
Recent Filings
75 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-12 | RCEL | Grant (A) | +2,000 | $7.9K | EDGAR |
| 2026-06-01 | RCEL | Grant (A) | +5,000 | $15.3K | EDGAR |
| 2026-05-20 | RCEL | Buy (P) | +2,000 | $8.5K | EDGAR |
| 2026-05-19 | RCEL | Buy (P) | +2,000 | $8.5K | EDGAR |
| 2026-03-11 | RCEL | Buy (P) | +1,800 | $8.6K | EDGAR |
| 2026-02-23 | RCEL | Buy (P) | +3,000 | $12.5K | EDGAR |
| 2026-02-19 | RCEL | Grant (A) | +105,470 | $0 | EDGAR |
| 2025-08-26 | RCEL | Buy (P) | +2,000 | $9.0K | EDGAR |
| 2025-08-12 | RCEL | Buy (P) | +2,000 | $9.6K | EDGAR |
| 2025-06-02 | RCEL | Grant (A) | +1,923 | $9.2K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.